Investigating the relationship between changes in metaphysical beliefs and death anxiety following a significant psychedelic experience
This exploratory study (n=155) investigates the relationship between changes in metaphysical beliefs and death anxiety following a significant psychedelic experience. It finds a significant overall reduction in death anxiety, with improvements correlated positively with increased belief in panpsychism, while no other metaphysical beliefs showed a correlation.
Abstract
Research examining the potential of the psychedelic experience to alter attitudes toward death is steadily emerging. However, the specific mechanisms leading to this change are not well understood. The present study investigated the potential relationship between changes in metaphysical beliefs and changes in death anxiety following a single significant psychedelic experience. A total of 155 participants completed a retrospective questionnaire that included questions about their acute experience and changes in death anxiety and metaphysical beliefs following a significant psychedelic experience. Although some participants reported an increase in death anxiety, there was an overall significant reduction in death anxiety from before to after the experience. Improvements in death anxiety were positively correlated with changes in belief in panpsychism, but no other measured metaphysical beliefs. The findings from this exploratory study provide direction for future research looking at the relationship between changes in metaphysical beliefs and death anxiety in the context of psychedelic experiences.
Research Summary of 'Investigating the relationship between changes in metaphysical beliefs and death anxiety following a significant psychedelic experience'
Introduction
A growing literature indicates that psychedelic drugs can produce durable psychological changes, including reductions in death anxiety and shifts in attitudes about mortality. Previous clinical and naturalistic studies have reported lower fear of death following single doses of psilocybin or LSD and psychedelic-induced phenomenology that resembles near-death experiences. However, the mechanisms linking psychedelic experiences to reduced death anxiety remain unclear. One candidate mechanism is change in metaphysical beliefs about the nature of reality and consciousness, ranging from physicalist positions to non-physicalist positions such as dualism or panpsychism; early work suggests psychedelics can produce lasting shifts away from strict physicalism and toward broader attributions of consciousness across entities. Moreton and colleagues set out to test whether changes in metaphysical beliefs following a single significant psychedelic experience are associated with changes in death anxiety. The study hypothesised an overall reduction in death anxiety, a shift away from physicalist beliefs toward non-physicalist beliefs, and correlations between those belief changes and changes in death anxiety. The investigators also predicted that acute subjective effects of the experience—mystical-type experiences and psychological insights—would predict changes in death anxiety and metaphysical beliefs, and included an exploratory aim to identify which specific metaphysical beliefs best predict changes in death anxiety.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Pro members can view the original manuscript directly in the browser.
Study Details
- Study Typeindividual
- Journal
- Topic
- Author
- APA Citation
Moreton, S. G., Barr, N. N., & Giese, K. J. (2025). Investigating the relationship between changes in metaphysical beliefs and death anxiety following a significant psychedelic experience. Death Studies, 49(5), 656-665. https://doi.org/10.1080/07481187.2024.2352726
References (26)
Papers cited by this study that are also in Blossom
Aday, J. S., Mitzkovitz, C. M., Bloesch, E. K. et al. · Neuroscience and Biobehavioral Reviews (2020)
Andersen, K. A. A., Carhart-Harris, R. L., Nutt, D. J. et al. · Acta Psychiatrica Scandinavica (2020)
Barrett, F. S., Johnson, M. W., Griffiths, R. R. · Journal of Psychopharmacology (2015)
Carhart-Harris, R. L., Goodwin, G. M. · Neuropsychopharmacology (2017)
Davis, A. K., Barrett, F. S., Griffiths, R. R. · Journal of Contextual Behavioral Science (2020)
Davis, A. K., Streeter Barrett, F., Griffiths, R. R. et al. · Journal of Psychopharmacology (2021)
Garcia-Romeu, A., Davis, A. K., Fire Erowid et al. · Journal of Psychopharmacology (2019)
Gasser, P., Holstein, D., Michel, Y. et al. · Journal of Nervous and Mental Disease (2014)
Griffiths, R. R., Hurwitz, E. S., Davis, A. K. et al. · PLOS ONE (2019)
Griffiths, R. R., Johnson, M. W. · Journal of Psychopharmacology (2016)
Show all 26 referencesShow fewer
Griffiths, R. R., Johnson, M. W., Richards, W. A. et al. · Psychopharmacology (2011)
Griffiths, R. R. · Journal of Psychopharmacology (2008)
Grob, C. S., Danforth, A. L., Chopra, G. S. et al. · JAMA Psychiatry (2011)
Acevedo, E. C., Uhler, S., White, K. et al. · Journal of Psychoactive Drugs (2024)
MacLean, K. A., Leoutsakos, J. S., Johnson, M. W. et al. · Journal for the Scientific Study of Religion (2012)
Moreton, S. G., Arena, A. F., Foy, Y. et al. · Death Studies (2023)
Moreton, S. G., Burden-Hill, A., Menzies, R. E. · Clinical Psychologist (2022)
Moreton, S. G., Szalla, L., Menzies, R. E. et al. · Psychopharmacology (2019)
Nayak, S., Griffiths, R. R. · Frontiers in Psychology (2022)
Nichols, D. E. · Pharmacological Reviews (2016)
Raison, C. L., Jain, R., Jain, S. et al. · Frontiers in Psychiatry (2022)
Ross, S., Bossis, A. P., Guss, J. et al. · Journal of Psychopharmacology (2016)
Swee, M. B., Nayak, S., Hurwitz, E. et al. · PLOS ONE (2022)
Timmermann, C., Kettner, H., Letheby, C. et al. · Scientific Reports (2021)
Timmermann, C., Roseman, L., Williams, L. et al. · Frontiers in Psychology (2018)
Tupper, K. W., Wood, E., Yensen, R. et al. · Canadian Medical Association Journal (2015)
Cited By (3)
Papers in Blossom that reference this study
Perkins, D., Halman, A., Urokohara, A. et al. · Scientific Reports (2025)
Dor-Ziderman, Y., David, J., Berkovich-Ohana, A. · Psychopharmacology (2025)
Kugel, J., Laukkonen, R., Yaden, D. B. et al. · Neuroscience and Biobehavioral Reviews (2025)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.